Monitoring Trustee Partners B.V. (“MTP"​) is one of the world’s leading companies providing monitoring trustee and divestiture trustee services.

Our team members have worked on more than 65 merger, dominance and state aid cases around the globe in all major industries such as pharmaceuticals, chemicals, energy, food and beverages, financial services, manufacturing and transportation. In this capacity we have worked with many of the largest multinationals. Moreover, MTP’s experience includes virtually all types of structural and behavioral remedies. This includes significant experience with complex M&A and carve-out projects. We have prepared more than 85 purchaser approval reports.

MTP combines the relevant trustee, industry, engineering, local and legal expertise. Our core team members have previously worked in outstanding corporate finance companies, banks and law firms such as Arthur Andersen, BNP Paribas, Capgemini Consulting, Duff & Phelps, EY, Landesbank Berlin, Peacock & Co, PwC, Société Générale and Standard & Poor’s. One of the core team members worked on a secondment basis with the European Commission during the financial crisis to assist the authority with potential state aid situations.

Our recent work includes the following cases:

• Broadcom / VMware - SAMR (China)
• Teva USA - No. 2:20-cr-200 DOJ (United States)
• Novozymes / Chr Hansen - M.11043 EC
• Hitachi / Thales - M.10507 EC and ME/6971/21CMA (UK)
• Advent / GfK - M.10860 EC
• Medivet / multiple veterinary businesses - ME/7022/22 CMA (UK)
• II-VI Incorporated / Coherent - SAMR (China)
• Celanese / DuPont Mobility & Materials - M.10721 EC
• Cellnex / CK Hutchison UK towers - ME/6917/20 CMA (UK)
• Ali Group / Welbilt – M.10431 EC
• Plus / Coop - 21/053545 ACM (NL)
• S&P / IHSM – CCB (CA), CMA (UK), M.10108 EC
• eBay / Adevinta - Z-5420 BWB (AT)
• Aon / WTW - M. 9829 EC
• TUI - SA.59812 EC
• Mastercard / Nets - M.9744 EC
• Uber / Careem – CCP (PK)
• Elanco / Bayer Animal Health - M.9554 EC
• AbbVie / Allergan - M.9461 EC
• Knauf / USG – ACCC (AU), NZCC (NZ)

Examples of engagements in connection with complex / multi-jurisdictional cases include:

S&P / IHSM – CCB (CA), CMA (UK), M.10108 EC

• S&P’s USD 44 billion acquisition of IHSM: MTP has been monitoring on behalf of the CCB (Canada), the CMA (United Kingdom) and the European Commission the divestiture of four divestment businesses and the proper execution of certain behavioral commitments. Involvement of four hold-separate managers and complex disentanglement of shared customer contracts. Purchasers of the various Divestment Businesses were FactSet, Morningstar and News Corporation.

Elanco / Bayer Animal Health M.9554 EC

• Elanco’s USD 7.6 billion acquisition of Bayer Animal Health: MTP has been mandated by the European Commission to monitor the sale process (including ring-fencing and viability) of four divestment businesses including several animal health pipeline and on-market products. Involvement of three hold-separate managers and four purchaser approvals. Purchasers of the Divestment Businesses were Dechra, MSD, Vetoquinol and Virbac.

Teva / Allergan Generics M.7746 EC

• Teva’s USD 39.6 billion acquisition of Allergan Generics: MTP has been mandated by the European Commission to monitor the divestiture process of a remedy package that comprised of 10 divestment businesses, including over 650 generics products in 26 EEA countries, a manufacturing plant in the UK and behavioral commitments. Involvement of three hold-separate managers and seven purchaser approvals. Purchasers of the businesses included Alvogen, Aurobindo and Intas/Accord Healthcare.

Maersk Line / Hamburg Süd M.8330 EC / FNE (CL) / SAMR (CN)

• Maersk Line’s EUR 3.7 billion acquisition of Hamburg Süd: MTP has been acting on behalf of the European Commission, the Fiscalía Nacional Económica (FNE, Chile) and the Ministry of Commerce people’s republic of China (SAMR, China) to monitor Maersk Line’s adherence to certain behavioral commitments related to container shipping trades covering Europe, the Americas and Asia.

ChemChina / Syngenta M.7962 EC / CCI (IN)/ FTC (US)

• ChemChina’s USD 43 billion acquisition of Syngenta: MTP has been monitoring on behalf of the European Commission, the FTC (the United States) and the Competition Commission of India (CCI, India) the divestiture of a broad portfolio of agrochemical products across a wide range of jurisdictions to Amvac and Nufarm and the proper execution of certain behavioral commitments.

If you would like to receive more information on MTP and on how we can be of assistance to your company, please contact us at + 31 20 210 5270 or at info@mtp.international.